| 1 |
陆普选，罗一婷，郑秋婷，等. 流行性感冒影像表现及最新国家诊疗方案要点[J]. 新发传染病电子杂志，2019, 4(1): 56-61.
|
| 2 |
张生信. 利巴韦林注射液联合痰热清超声雾化治疗流感病毒感染致病毒性肺炎的效果观察[J]. 世界最新医学信息文摘，2019, 19(54): 171-172.
|
| 3 |
Emukule GO, Namagambo B, Owor N, et al. Influenza-associated pneumonia hospitalizations in Uganda, 2013-2016[J]. PLoS One, 2019, 14(7): e0219012.
|
| 4 |
Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology[J]. Crit Care, 2019, 23(1): 258.
|
| 5 |
林秀慧，张根生，崔 巍. 病毒性肺炎的诊治进展[J]. 中国现代医生，2017, 55(5): 163-168.
|
| 6 |
Choi JG, Kim YS, Kim JH, et al. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition[J]. Sci Rep, 2019, 9(1): 12132.
|
| 7 |
张红波，莫尚鹏，陈玉红，等. 宜春市2011年至2012年乙型流感病毒耐药基因分析[J]. 实验与检验医学，2017, 35(1): 49-51, 67.
|
| 8 |
刘心悦，蒋荣猛. 儿童流行性感冒抗病毒药物研究进展[J]. 中华儿科杂志，2019, 57(4): 313-316.
|
| 9 |
王丽燕，刘田田. 帕拉米韦氯化钠注射液治疗儿童流感病毒感染的临床疗效和安全性对比[J]. 中国医院药学杂志，2018, 38(12): 1307-1310.
|
| 10 |
陈灏珠，林果为. 实用内科学[M]. 13版，北京：人民卫生出版社，2011: 1774-1776.
|
| 11 |
国家卫生和计划生育委员会. 流行性感冒诊疗方案(2018年版)[J]. 中国病毒病杂志，2018, 8(2): 81-85.
|
| 12 |
Lee J, Park JH, Jwa H, et al. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis[J]. Yonsei Med J, 2017, 58(4): 778-785.
|
| 13 |
Peteranderl C, Herold S, Schmoldt C. Human Influenza Virus Infections [J]. Semin Respir Crit Care Med, 2016, 37(4): 487-500.
|
| 14 |
Harmon TS, Olano JP, Nguyen QD, et al. David Versus Goliath: The Clinical Consequences of an Influenza A Viral Infection in an Unvaccinated Patient[J]. Cureus, 2019, 11(5): e4788.
|
| 15 |
Ishiguro T, Matsuo K, Fujii S, et al. Acute thrombotic vascular events complicating influenza-associated pneumonia[J]. Respir Med Case Rep, 2019, 28: 100884.
|
| 16 |
Jochems SP, Marcon F, Carniel BF, et al. Inflammation induced by influenza virus impairs human innate immune control of pneumococcus[J]. Nat Immunol, 2018, 19(12): 1299-1308.
|
| 17 |
王 健，张 慧，毛丽萍，等. 甲型流感患者相关实验室指标与病程的关系研究[J]. 南通大学学报(医学版), 2018, 38(5): 367-369.
|
| 18 |
高海女，汤灵玲，李兰娟. 流行性感冒：抗病毒治疗是关键！[J]. 中华临床感染病杂志，2018, 11(1): 6-10.
|
| 19 |
李希妍，黄维娟，成艳辉，等. 2014-2015监测年度中国B型流感病毒对神经氨酸酶抑制剂的敏感性[J]. 中华微生物学和免疫学杂志，2016, 36(10): 753-757.
|
| 20 |
Saisho Y, Ishibashi T, Fukuyama H, et al. Pharmacokinetics and safety of intravenous peramivir, neuraminidase inhibitor of influenza virus, in healthy Japanese subjects[J]. Antivir Ther, 2017, 22(4): 313-323.
|
| 21 |
Hernandez JE, Adiga R, Armstrong R, et al. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States[J]. Clin Infect Dis, 2011, 52(6): 695-706.
|
| 22 |
陈圣洁，戴兰芬，李丹丹，等. 帕拉米韦与奥司他韦治疗儿童流感病毒肺炎的成本-效果分析[J]. 中国医药，2019, 14(2): 215-218.
|
| 23 |
Tanaka A, Nakamura S, Seki M, et al. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice[J]. Antivir Ther, 2015, 20(1): 11-19.
|
| 24 |
Yoo JW, Choi SH, Huh JW, et al. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza[J]. J Med Virol, 2015, 87(10): 1649-1655.
|
| 25 |
刘秀菊，董维冲，郭鹏辉，等. 大鼠血浆中帕拉米韦的HPLC法测定及其药动学[J]. 中国医药工业杂志，2016, 47(6): 751-754.
|
| 26 |
Scott LJ. Peramivir: A Review in Uncomplicated Influenza[J]. Drugs, 2018, 78(13): 1363-1370.
|
| 27 |
Wester A, Shetty AK. Peramivir injection in the treatment of acute influenza: a review of the literature[J]. Infect Drug Resist, 2016, 9: 201-214.
|
| 28 |
Bantia S, Arnold CS, Parker CD, et al. Anti-influenza virus activity of peramivir in mice with single intramuscular injection[J]. Antiviral Res, 2006, 69(1): 39-45.
|
| 29 |
McLaughlin MM, Skoglund EW, Ison MG. Peramivir: an intravenous neuraminidase inhibitor[J]. Expert Opin Pharmacother, 2015, 16(12): 1889-1900.
|